Ever Source Wealth Advisors, LLC Intellia Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 270 shares of NTLA stock, worth $2,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
270
Previous 1,747
84.54%
Holding current value
$2,932
Previous $35,000
91.43%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$136 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$111 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$104 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$56.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$41.4 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $825M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...